A 2.7-kb portion of the 5' flanking region of the murine glycoprotein alpha(IIB) gene is transcriptionally active in primitive hematopoietic progenitor cells

被引:45
作者
Tropel, P
Roullot, V
Vernet, M
Poujol, C
Pointu, H
Nurden, P
Marguerie, G
TronikLeRoux, D
机构
[1] CEA, DEPT BIOL MOL & STRUCT, LAB TRANSGENESE & DIFFERENCIAT CELLULAIRE, F-38054 GRENOBLE 9, FRANCE
[2] HOP CARDIOL, CNRS, UMR 5533, LAB HEMOBIOL, PESSAC, FRANCE
关键词
D O I
10.1182/blood.V90.8.2995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The continuous generation of mature blood cells from primitive multipotent progenitor cells requires a highly complex series of cellular events that are still largely unknown. To examine the molecular events associated with the commitment of these hematopoietic progenitor cells to the megakaryocytic lineage, the alpha subunit of the platelet integrin alpha(IIb)beta(3) was used as marker. Despite an abundance of information regarding the role of this integrin in platelet adhesion and aggregation, the mechanisms that control the expression of the genes that code for these proteins are poorly understood and the earliest hematopoietic cell capable of expressing them has not been clearly identified. Thus, a strategy was developed to eradicate, using a conditional toxigene, all the hematopoietic cells capable of expressing the alpha(IIb) gene in mice. This was achieved by targeting the expression of the gene encoding the herpes simplex virus thymidine kinase (tk), specifically to these cell types, using a 2.7-kb fragment of the 5'-flanking region of the murine alpha(IIb) gene. Three transgenic lines having 1, 3, and 4 copies of the transgene, respectively were produced and analyzed. Administration of ganciclovir (GCV) to these mice induced a severe thrombocytopenia, which was due to the depletion of the entire megakaryocytic lineage, as shown by bone marrow (BM) culture and electron microscopy analysis. The time required to attain a severe thrombocytopenia was dependent on the level of the expression of the transgene and varied from 7 to 11 days. This condition was completely reversed when GCV treatment was discontinued. Progenitor cell assays showed that the alpha(IIb) promoter was active in primitive hematopoietic progenitor cells possessing myeloid, erythroid, and megakaryocytic potential and that the transcriptional activity of the promoter decreased progressively as differentiation proceeded towards the erythroid and myeloid lineages. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2995 / 3004
页数:10
相关论文
共 48 条
[1]   Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].
Alexander, WS ;
Roberts, AW ;
Nicola, NA ;
Li, RL ;
Metcalf, D .
BLOOD, 1996, 87 (06) :2162-2170
[2]   THE HERPES-SIMPLEX VIRUS TYPE-1 THYMIDINE KINASE IS EXPRESSED IN THE TESTES OF TRANSGENIC MICE UNDER THE CONTROL OF A CRYPTIC PROMOTER [J].
ALSHAWI, R ;
BURKE, J ;
WALLACE, H ;
JONES, C ;
HARRISON, S ;
BUXTON, D ;
MALEY, S ;
CHANDLEY, A ;
BISHOP, JO .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (08) :4207-4216
[3]  
[Anonymous], 1994, MANIPULATING MOUSE E
[4]  
BAI Y, 1984, BLOOD, V64, P139
[5]   EXPRESSION OF CD4 BY HUMAN MEGAKARYOCYTES [J].
BASCH, RS ;
KOURI, YH ;
KARPATKIN, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (20) :8085-8089
[6]  
BERRIDGE MV, 1985, BLOOD, V66, P76
[7]   SERUM-FREE MEDIUM ALLOWS THE OPTIMAL-GROWTH OF HUMAN MEGAKARYOCYTE PROGENITORS COMPARED WITH HUMAN PLASMA SUPPLEMENTED CULTURES - ROLE OF TGF-BETA [J].
BERTHIER, R ;
VALIRON, O ;
SCHWEITZER, A ;
MARGUERIE, G .
STEM CELLS, 1993, 11 (02) :120-129
[8]  
BLOCK KL, 1994, BLOOD, V84, P3385
[9]  
CarverMoore K, 1996, BLOOD, V88, P803
[10]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552